Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

BACKGROUND: The stimulant methylphenidate (MPH) has been a mainstay of treatment for attention-deficit/hyperactivity disorder (ADHD) for many years. Owing to the short half-life and the issues associated with multiple daily dosing of immediate-release MPH formulations, a new generation of long-actin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Coghill, David, Banaschewski, Tobias, Zuddas, Alessandro, Pelaz, Antonio, Gagliano, Antonella, Doepfner, Manfred
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852277/
https://ncbi.nlm.nih.gov/pubmed/24074240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-13-237
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky